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ABSTRACT
Animal bites have always been a common problem to humans. The incidence of resistant organisms is also
increasing in the community. Garenoxacin a novel oral des-fluoroquinolone with potent antimicrobial activity
against common pathogens causing skin and soft tissue infections, including resistant strains offers the benefit of
broad spectrum of coverage including gram positive, gram negative and anaerobic organisms. The result of the
case study indicates that garenoxacin is very effective in treating skin and soft tissue infections caused by animal
bites.
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INTRODUCTION
Animal  and  human  bites  are  a  common  problem
1.
Proper care requires wound inspection for injury to
deeper structures; meticulous wound care at the initial
encounter; and decisions regarding primary closure,
the provision of prophylactic antibiotics for wounds
at high risk for infection, and prophylaxis for tetanus
and  rabies  as  indicated.  In  case  of  inadequate  or
undertreated  cases, Extensive  morbidity,  including
disability and cosmetic damage is expected to be a
foregone conclusion due to underlying infection
For wounds that appear infected at the time of initial
assessment, antibiotic therapy is usually started after
Gram stain and/orculture reports are made available.
2
There is a lack of controlled studies evaluating the
use of different antibiotics in infected bite wounds.
Empirical treatment  should  be  directed  toward  the
most common infecting organisms. The predominant
pathogens in animal bite wounds are the oral flora of
the  biting  animal  and  human  skin  flora.  Infection
usually results from a mixture of organisms. Common
pathogens include Pasteurella species, staphylococci,
streptococci, and anaerobic bacteria.
Circumstances  when the  use  of  prophylactic
antibiotics may be used include
Table 1: Prophylactic use of antibiotics
Dog bites more than 8-12 hours old
Moderate  to  severe  dog  bite  less  than  8-12  hours
(Oedema, Crush injuries)
Puncture  wounds,  particularly  if  bone  or  joints were
penetrated
Severe facial wounds
All hand bites
Wounds in the genital area
Wounds in immunocompromised or asplenic patients
Moderate to severe cat or human bites
CASE STUDY
A female  aged  68  years  weighing  52kgs  was
presented to a Doctor in a tertiary care setting. The
patient presented with facial trauma due to bear attack
leading  to  disfigurement  of  the  face. This  event
occurred  a  day  prior  to presentation  when  she
wandered  into  the  outskirts  of  her  village  for
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household  chores. Patient was  conscious, averagely
built and had vital parameters including temperature,
pulse and respiratory rate within normal limits. She
had  no  history  of  any  chronic  illnesses, including
diabetes mellitus or tuberculosis in the past. Similarly
no  icterus or  generalized  lymphadenopathy  was
observed.The patient was stabilized and wounds were
cleaned  and  dressed  for  further  action. A
reconstructive surgery was performed on the face on
the  same  day  with  excision  sample was sent  for
further  analysis  and  culture.  The  culture  report
showed P. aeruginosa & S. aureus on the third day.
As  Surgical  prophylaxis,  patient  received
Amoxicillin-clavulanate injection 1.2 g every 8 hours
with Metronidazole 500 mg every 8 hours for three
days. The patient accepted oral feeds on the third day
and shifted to Garenoxacin tablets (400 mg OD) for
10 days. Clinical inflammatory response around the
surgical flaps subsided within five days. There was
no graft rejection, discharge, dehiscence or infection
nidus around the sutures. The sutures were removed
after 15 days
Fig 2:    Before  and  after  treatment  pictures of
facial  disfigurement  in  patient  who  sustained
trauma due to Bear attack
DISCUSSION
Facial laceration or injury remains an important cause
of cosmetic disfigurement unless closed. Infection of
these  wounds  is common, perhaps  due  to  the
excellent  blood  supply  to  the  face  and  scalp.
Provision of proper wound care is essential for good
outcomes  and  to  reducing  infection  risk  in patients
who undergo wound closure. When bite wounds are
sutured, extensive irrigation, debridement, avoidance
of  deep  sutures  (if  possible),  institution  of
prophylactic antibiotic therapy, and close follow-up
are indicated. A common approach involves initial IV
therapy until infection is resolving followed by oral
therapy to complete a course of 10 to 14 days.
Aggressive  wound  management  of  animal  bite
wounds  is  thought  to  decrease  the  infection rate
2.
Cleansing of the wound with a few hundred mL of
high pressure saline is usually effective. Removal of
devitalized tissues is also important to prevent a nidus
of infection.
Despite  the  lack  of  prospective  studies,  primary
wound  closure  is  not  typically  performed  on  bite
wounds.  In  general,  bite  wounds  are  left  open,
reevaluated  within  2  to  3  days,  and  managed  by
secondary intention or delayed primary closure. Some
retrospective  studies  have also  suggested primary
closure of puncture wounds, crush injuries, wounds
that  are  more  than  24  hours  old,  wounds  over  the
hands,  wrists,  feet  and  joints,  wounds  in
immunocompromised  individuals,  and  wounds
inflicted  by  cats  or  humans
3.  Once  the  wound  has
been observed for a few days and there are no signs
of infection delayed closure can be attempted. Non-
infected  facial  wounds  less  than  24  hours old  can
probably be repaired
4. Facial wounds can be closed
with  high  rates  of  success,  probably  due  to  high
vascularity and absence of dependent edema.
For wounds that appear infected at the time of initial
assessment, antibiotic therapy should be started after
a Gram stain and aerobic and anaerobic cultures have
been obtained. There is a lack of controlled studies
evaluating the use of different antibiotics in infected
bite  wounds.  Empiric  treatment  should  be  directed
toward the most common infecting organisms.
Garenoxacin,  a  recently  introduced  des-
fluoro(6)quinolone  in  India  offers  broad  yet  potent
spectrum  of  activity  against  Gram  positive,  Gram
negative  and  Anaerobic  pathogens
5,6The  excellent
clinical response observed with Garenoxacin during
the  post-operative  period  probably highlights its
clinical  utility  as a useful  ‘switch’  therapy  while
preventing post-surgical infections
CONCLUSION
Garenoxacin  offers a broad  spectrum  of  activity
against various pathogens involved in skin and soft
tissue  infections  including  gram  positive,  gram
negative  and  anaerobic  organisms.  Garenoxacin
appears  to  be  a  suitable  option  for  the  resistant  or
difficult  to  treat  infections and add to  the
armamentarium of the clinicians.505
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